Clinical Trial Update: Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

View source ↗

Summary

A prospective exploratory clinical study using transcriptome sequencing to guide precision therapy for osteosarcoma, with the trial status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Osteosarcoma, Transcriptome | Status: NOT_YET_RECRUITING